{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:56:44Z","timestamp":1792601804247,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,15]]},"DOI":"10.1093\/hmg\/ddp333","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T00:25:34Z","timestamp":1248308734000},"page":"3906-3913","source":"Crossref","is-referenced-by-count":92,"title":["Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model"],"prefix":"10.1093","volume":"18","author":[{"given":"Virginia B.","family":"Mattis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison D.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Y.","family":"Fosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,7,21]]},"reference":[{"key":"key\n\t\t\t\t20170522132506_DDP333C1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522132506_DDP333C2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch. Neurol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1086\/302160","article-title":"Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number","volume":"63","author":"Parsons","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132506_DDP333C5","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522132506_DDP333C6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","article-title":"An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN","volume":"9","author":"Lorson","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0598-63","article-title":"SMN oligomerization defect correlates with spinal muscular atrophy severity","volume":"19","author":"Lorson","year":"1998","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C8","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1371\/journal.pone.0000921","article-title":"Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs","volume":"2","author":"Gabanella","year":"2007","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522132506_DDP333C9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2008.06.059","article-title":"A SMNDelta7 read-through product confers functionality to the SMNDelta7 protein","volume":"442","author":"Mattis","year":"2008","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170522132506_DDP333C10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12031-007-0024-5","article-title":"Smn depletion alters profilin II expression and leads to upregulation of the RhoA\/ROCK pathway and defects in neuronal integrity","volume":"32","author":"Bowerman","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C11","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1523\/JNEUROSCI.1637-06.2006","article-title":"Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis","volume":"26","author":"Carrel","year":"2006","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis","volume":"90","author":"Fischer","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132506_DDP333C13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing","volume":"95","author":"Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132506_DDP333C14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0955-0674(00)00211-8","article-title":"Spliceosomal UsnRNP biogenesis, structure and function","volume":"13","author":"Will","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132506_DDP333C16","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.23-16-06627.2003","article-title":"Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization","volume":"23","author":"Zhang","year":"2003","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/hmg\/9.1.47","article-title":"Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord","volume":"9","author":"Pagliardini","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1460-9568.1999.00428.x","article-title":"Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport","volume":"11","author":"Bechade","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell. Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J. Cell. Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C23","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C24","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/hmg\/ddn234","article-title":"SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain","volume":"17","author":"Walker","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C25","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/jnr.21308","article-title":"QNQKE targeting motif for the SMN-Gemin multiprotein complexin neurons","volume":"85","author":"Zhang","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170522132506_DDP333C26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","article-title":"Translational readthrough by the aminoglycoside genetecin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo","volume":"18","author":"Heier","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","article-title":"Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts","volume":"120","author":"Mattis","year":"2006","journal-title":"Hum. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","article-title":"A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels","volume":"14","author":"Wolstencroft","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522132506_DDP333C30","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","article-title":"Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector","volume":"75","author":"Passini","year":"2001","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1089\/hum.2008.067","article-title":"A negatively-acting bifunctional RNA increases survival motor neuron in vitro and in vivo","volume":"19","author":"Dickson","year":"2008","journal-title":"Hum. Gene. Ther"},{"key":"key\n\t\t\t\t20170522132506_DDP333C32","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","article-title":"Development of a single vector system that enhances trans-splicing of SMN2 transcripts","volume":"3","author":"Coady","year":"2008","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522132506_DDP333C33","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C34","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/hmg\/ddp076","article-title":"Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy","volume":"18","author":"Baughan","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20170522132506_DDP333C35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","article-title":"Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice","volume":"29","author":"Kong","year":"2009","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C36","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddn189","article-title":"Embryonic motor axon development in the severe SMA mouse","volume":"17","author":"McGovern","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","article-title":"Therapeutics development for spinal muscular atrophy","volume":"3","author":"Sumner","year":"2006","journal-title":"NeuroRx"},{"key":"key\n\t\t\t\t20170522132506_DDP333C38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-540-34449-0_6","article-title":"Spinal muscular atrophy and therapeutic prospects","volume":"44","author":"Wirth","year":"2006","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170522132506_DDP333C42","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.chembiol.2004.08.024","article-title":"Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism","volume":"11","author":"Lunn","year":"2004","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"Burnett","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0969-2126(01)00629-3","article-title":"Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site","volume":"9","author":"Vicens","year":"2001","journal-title":"Structure"},{"key":"key\n\t\t\t\t20170522132506_DDP333C46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/jmbi.1996.0526","article-title":"RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide","volume":"262","author":"Recht","year":"1996","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C47","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin","volume":"13","author":"Burke","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170522132506_DDP333C48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02464911","article-title":"Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells","volume":"217","author":"Martin","year":"1989","journal-title":"Mol. Gen. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0496-467","article-title":"Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations","volume":"2","author":"Howard","year":"1996","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132506_DDP333C51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132506_DDP333C52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0091270006297140","article-title":"Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers","volume":"47","author":"Hirawat","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20170522132506_DDP333C53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522132506_DDP333C54","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"Du","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522132506_DDP333C55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","article-title":"Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial","volume":"372","author":"Kerem","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522132506_DDP333C56","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1007\/s00018-004-4300-z","article-title":"Modulation of SMN nuclear foci and cytoplasmic localization by its C-terminus","volume":"61","author":"Hua","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"key\n\t\t\t\t20170522132506_DDP333C57","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","article-title":"Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo","volume":"18","author":"Heier","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2007.04.009","article-title":"Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy","volume":"27","author":"Butchbach","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522132506_DDP333C59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/hmg\/ddn426","article-title":"Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy","volume":"18","author":"Rose","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132506_DDP333C60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/18\/20\/3906\/17247770\/ddp333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T16:46:44Z","timestamp":1558457204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddp333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,21]]},"references-count":60,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2009,7,21]]},"published-print":{"date-parts":[[2009,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddp333","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,21]]}}}